Gillian Stynes | Executive Director, Global Market Access & Pricing
Merck

Dr. Gillian Stynes is an accomplished pharmaceutical executive with extensive experience in developing and executing successful global pricing & reimbursement strategies. She possesses a deep understanding of HTA, pricing dynamics, payer policy and market trends, allowing her to navigate complex launches across global markets with precision and insight.  With a proven track record of launching innovative medicines across multiple therapy areas, Gillian is known for her dynamic mindset and innovative approach to pricing and access challenges. Her superpower comes from leveraging both technical expertise and business acumen to identify unique, evidence-backed strategies and to activate broad stakeholder engagement.
At the World EPA Congress USA 2027, Gillian will share her insights on navigating the evolving global landscape of healthcare pricing, access, and evidence. Her commitment to improving patient access to innovative therapies and driving value for all stakeholders make her a key leader in the industry.